As per the tentative results of WHO s evaluation, out of the 23 samples of the products under reference were tested, of which four were found to contain Diethylene Glycol or Ethylene glycol.
A joint inspection by Haryana’s Food and Drug Administration (FDA) and the Union government’s drug regulator, the CDSCO, found 12 violations in the firm's manufacturing plant and issued notice for production to be stopped.
The fatal contaminants found in the cough syrups have been responsible for deaths in India in the past, in products made by the same manufacturer no less. But no word has come from the CDSCO as yet.
The state authority has warned Maiden Pharmaceuticals to reply within seven days, failing which the officials will take ex-parte action against the firm as per the drugs act.
New Delhi: The Indian Pharma company Maiden Pharmaceuticals on Saturday expressed shock over the media reports regarding the deaths of 66 children in the Gambia after consuming cough syrup.